Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/ncb3281 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: Wieder, R.; Adam, N. Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data. 2023, , 4333.
Cancers (Basel)
June 2024
Phalcon, LLC, Manhasset, NY 11030, USA.
[...
View Article and Find Full Text PDFAddendum: ACSL4: biomarker, mediator and target in quadruple negative breast cancer.
Oncotarget
August 2023
Department of Neuroscience and Physiology, NYU Grossman School of Medicine, New York, NY 10016, USA.
Pembrolizumab-induced nephrotoxicity in a patient with breast cancer.
Ther Adv Med Oncol
April 2024
Division of Hematology/Oncology, Fred Hutchinson Cancer Center, University of Washington School of Medicine, Seattle, WA, USA.
The introduction of immunotherapy has revolutionized the treatment and improved outcomes of multiple types of cancer. Although breast cancer is a less immune-responsive tumor type, the incorporation of pembrolizumab into chemotherapy regimens in the neoadjuvant and first-line metastatic setting for the triple-negative disease has improved outcomes. However, the use of this type of treatment is associated with a spectrum of adverse events.
View Article and Find Full Text PDFAmendments in surgical pathology reports: An 8-year institutional experience.
Ann Diagn Pathol
August 2024
Department of Pathology, Rajiv Gandhi Cancer Institute & Research Centre, New Delhi 110085, India.
Surgical pathology reports may undergo revisions broadly categorized as addenda (supplementary information) or amendments (changes to finalized reports). Amendments indicate potential flaws in the diagnostic process and serve as important indicators of vulnerabilities in the histopathology workflow. This study analyzed the frequency and distribution of amendments in surgical pathology reports over 8 years to identify patterns highlighting opportunities for improvement.
View Article and Find Full Text PDFAddendum: Crosstalk between triple negative breast cancer and microenvironment.
Oncotarget
September 2023
Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Science, Albany, NY 12208, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!